id,pmid,year,seq,MAP,name,cter,nter,lyn_cyc,ldmix,non_nat,len,nature,activity,source,origin,exp_str,non_hem,dssp,smiles
5986,25425644,2015,T1 -VVLVGIAGVALVV- T2,{nnr:T1}-VVLVGIAGVALVV- {nnr:T2},TM4(88–100)scr,Free,Free,Stapled,L,"T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH7",13,Antimicrobial,Not specified,Human,Synthetic,α-Helical,NA,NA,NA
5987,25425644,2015,T1 -VVGLXLIVXGVVV-T2,{nnr:T1}-VVGL{nnr:X}LIV{nnr:X}GVVV-{nnr:T2},S-TM4(88–100),Free,Free,Stapled,L,"T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH8",13,Antimicrobial,10 % Hemolysis at 12.5 µM,Human,Synthetic,α-Helical,NA,NA,NA
5988,25425644,2015,T1 -VVGLXLIGXGVVV-T2,{nnr:T1}-VVGL{nnr:X}LIG{nnr:X}GVVV-{nnr:T2},S-TM4(88–100)-G95,Free,Free,Stapled,L,"T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH9",13,Antimicrobial,10 % Hemolysis at 25 µM,Human,Synthetic,α-Helical,NA,NA,NA
5989,25425644,2015,T1 -VVGLXLINXGVVV-T2,{nnr:T1}-VVGL{nnr:X}LIN{nnr:X}GVVV-{nnr:T2},S-TM4(88–100)-N95,Free,Free,Stapled,L,"T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH10",13,Antimicrobial,10 % Hemolysis at >200 µM,Human,Synthetic,α-Helical,NA,NA,NA
5990,25425644,2015,T1 -VX'GLALINXGVVV-T2,{nnr:T1}-V{nnr:X'}GLALIN{nnr:X}GVVV-{nnr:T2},S1-TM4(88–100)-N95,Free,Free,Stapled,L,"T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH11",13,Antimicrobial,10 % Hemolysis at 100 µM,Human,Synthetic,α-Helical,NA,NA,NA
5991,25425644,2015,T1 -VVGLX'LINAGVXV-T2,{nnr:T1}-VVGL{nnr:X'}LINAGV{nnr:X}V-{nnr:T2},S2-TM4(88–100)-N95,Free,Free,Stapled,L,"T1 = CH3CO-Ala-Sar3-(N-methyl-Gly), T2 = -Lys3-NH12",13,Antimicrobial,10 % Hemolysis at 100 µM,Human,Synthetic,α-Helical,NA,NA,NA
7179,28230992,2017,LRRLRRRLRRLRRRWRRRLRRLRRRLRRL,LRRLRRRLRRLRRRWRRRLRRLRRRLRRL{ct:Amid},6,Amidation,Free,Branched,L,None,29,Antibacterial,10 % Hemolysis at 64 mg/L,Human,Synthetic,α-Helix,NA,CHHHHHHHHHHTTHHHHHHHHHGGGGGCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)O
7180,28230992,2017,LRRLRRRLRRLRRRLRRLRRRWRRRLRRLRRRLRRLRRRLRRL,LRRLRRRLRRLRRRLRRLRRRWRRRLRRLRRRLRRLRRRLRRL{ct:Amid},7,Amidation,Free,Branched,L,None,43,Antibacterial,10 % Hemolysis at 64 mg/L,Human,Synthetic,α-Helix,NA,CHHHHHHHHHHTTHHHHHGGGTTHHHHHHTHHHHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)O
9017,29473887,2018,(KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF)4-arm-PEG-PLGA,KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF{conj:4-arm-PEG-PLGA},cathelicidin-BF-30loaded 4-arm-PEG-PLGA,Free,Free,NA,L,4-arm-PEG-PLGA = ethylene glycol-b-dl-lactic acid-co-glycolic acid(microspheres),30,Antimicrobial,~15 % Hemolysis at 1000 μg/ml,Rabbit,Snake Venoms Of Bungarus Fasciatus,α-Helical,NA,NA,NA
9045,29551999,2018,RRWQWRRRWQWRKAhx,RRWQWRRRWQWRK{nnr:Ahx},Dimeric (LfcinB (20–25)2),Free,Free,Branched,L,Ahx = hydrophobic spacer that prevents steric hindrance,15,Antibacterial,5.6 % Hemolysis at 100 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,NA,NA
9046,29551999,2018,RRWQWRRRWQWRRRWQWRRRWQWRKKAhxAhxCC,RRWQWRRRWQWRRRWQWRRRWQWRKK{nnr:Ahx}{nnr:Ahx}CC,Tetrameric (LfcinB (20–25)4),Free,Free,Branched,L,Ahx = hydrophobic spacer that prevents steric hindrance,30,Antibacterial,49.1 % Hemolysis at 100 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,NA,NA
9050,29551999,2018,RRWQWRRRWQWRKAhx,RRWQWRRRWQWRK{nnr:Ahx},Dimeric (LfcinB (20–25)2),Free,Free,Branched,L,Ahx = hydrophobic spacer that prevents steric hindrance,15,Antibacterial,50 % Hemolysis at >100 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,NA,NA
9051,29551999,2018,RRWQWRRRWQWRRRWQWRRRWQWRKKAhxAhxCC,RRWQWRRRWQWRRRWQWRRRWQWRKK{nnr:Ahx}{nnr:Ahx}CC,Tetrameric (LfcinB (20–25)4),Free,Free,Branched,L,Ahx = hydrophobic spacer that prevents steric hindrance,30,Antibacterial,50 % Hemolysis at >100 µM,Human,Bovine Lfcinb -Lactoferricin B (Lfcinb)-Based Synthetic Peptides,NA,NA,C,NA
9053,29275987,2018,KKKKKK-AAFXAWAXFAA,KKKKKKAAF{nnr:X}AWA{nnr:X}FAA{ct:Amid},S-6K-F17,Amidation,6 Lys,Stapled,L,X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined,17,Antibacterial,2 % Hemolysis at 4 µM,Human,6K-F17 Hydrocarbon Staple,Random coil,NA,NA,NA
9054,29275987,2018,KKKKKK-AGFXAWAXFGA,KKKKKKAGF{nnr:X}AWA{nnr:X}FGA{ct:Amid},S-6K-F17-2G,Amidation,6 Lys,Stapled,L,X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined,17,Antibacterial,MHC at 15[5.8] µM,Human,6K-F17 Hydrocarbon Staple,NA,NA,NA,NA
9055,29275987,2018,KKKKKK-AGFXAWGXFGA,KKKKKKAGF{nnr:X}AWG{nnr:X}FGA{ct:Amid},S-6K-F17-3G,Amidation,6 Lys,Stapled,L,X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined,17,Antibacterial,MHC at 128[43.8] µM,Human,6K-F17 Hydrocarbon Staple,Random coil,NA,NA,NA
9056,29275987,2018,KKKKKK-NGFXAWGXFGA,KKKKKKNGF{nnr:X}AWG{nnr:X}FGA{ct:Amid},S-6K-F17-3GN,Amidation,6 Lys,Stapled,L,X = Ala residues replaced by 2-(40 -pentenyl)alanine residues are underlined,17,Antibacterial,MHC at 587[130.6] µM,Human,6K-F17 Hydrocarbon Staple,Helical,NA,NA,NA
9400,29770868,2018,GIGAVLKVLTTGLPALISWIKRKRQQ-(Dab-NH2)-GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{nnr:Dab-NH2}GIGAVLKVLTTGLPALISWIKRKRQQ,melittin dimer,Free,Free,Branched,L,"Dab = 3,3ʹ-diaminobenzidine",52,Antibacterial,100 % Hemolysis at 10 µM,mouse,Synthetic Dimer Of Melittin,NA,NA,NA,NA
11763,33532575,2021,KLKLKLKLKLKLKLKLKKLKKLKKLKKLKKLKKLKKL,KLKLKLKLKLKLKLKLKKLKKLKKLKKLKKLKKLKKL,L-G3KL,Free,Free,Branched,L,None,37,Antibacterial. Antibiofilm,MHC at 1000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CTTCCCCCCCGGGHHHHHHHHHHHHHHHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11764,33532575,2021,klklklklklklklklkklkklkklkklkklkklkkl,K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d},D-G3KL,Free,Free,Branched,D,None,37,Antibacterial. Antibiofilm,MHC at 1000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CCSTTTSCSSCCCCCCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11765,33532575,2021,OFOFOFOFKBLKBLKKLK(C10),OFOFOFOFKBLKBLKKLK{ct:C10},L-TNS18,C10,Free,Branched,L,C10,18,Antibacterial. Antibiofilm,MHC at 1000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CGGGGTTTTSCSCCCCCCCSCCC,NA
11766,33532575,2021,ofofofofkblkblkklk(C10),O{d}F{d}O{d}F{d}O{d}F{d}O{d}F{d}K{d}B{d}L{d}K{d}B{d}L{d}K{d}K{d}L{d}K{d}{ct:C10},D-TNS18,Free,Free,Branched,D,None,18,Antibacterial. Antibiofilm,MHC at 500 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Low hemolytic,CCSTTTSTTCCCSSCCCCCCCCC,NA
11767,33532575,2021,KLKLKLKLKLKLKLKLKKLKKLKKLKKLKLLKLLKKLL,KLKLKLKLKLKLKLKLKKLKKLKKLKKLKLLKLLKKLL,L-T25,Free,Free,Branched,L,None,38,Antibacterial. Antibiofilm,MHC at 62.5 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,NA,CTTHHHHTTSCCCSSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11768,33532575,2021,klklklklklklklklkklkklkklkklkllkllkkll,K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}L{d}L{d}K{d}L{d}L{d}K{d}K{d}L{d}L{d},D-T25,Free,Free,Branched,D,None,38,Antibacterial. Antibiofilm,MHC at 125 μg/ml,Human,Synthetic Peptide,NA,NA,CCCTTHHHHHHHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
12398,34966367,2021,G-S5-LKR-S5-KTLL,G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid},Anoplin[2-6],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,9.1 % Hemolysis at 64 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12399,34966367,2021,G-S5-LKR-S5-KTLL,G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid},Anoplin[2-6],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,4 % Hemolysis at 32 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12400,34966367,2021,G-S5-LKR-S5-KTLL,G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid},Anoplin[2-6],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,2.8 % Hemolysis at 16 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12401,34966367,2021,G-S5-LKR-S5-KTLL,G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid},Anoplin[2-6],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,2.4 % Hemolysis at 8 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12402,34966367,2021,G-S5-LKR-S5-KTLL,G-{nnr:S5}-LKR-{nnr:S5}-KTLL{ct:Amid},Anoplin[2-6],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,2.1 % Hemolysis at 4 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12403,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},Anoplin[5-9],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,62.7 % Hemolysis at 64 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12404,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},Anoplin[5-9],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,43.2 % Hemolysis at 32 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12405,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},Anoplin[5-9],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,29.8 % Hemolysis at 16 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12406,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},Anoplin[5-9],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,16.6 % Hemolysis at 8 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12407,34966367,2021,GLLK-S5-IKT-S5-L,GLLK-{nnr:S5}-IKT-{nnr:S5}-L{ct:Amid},Anoplin[5-9],Amidation,Free,Stapled,L,S5 = Olefinic,8,Antibacterial,6.5 % Hemolysis at 4 µM,Sheep,Anoplin Analogs,"phosphate buffer = α-Helical, membrane-mimicking environments = α-Helical",NA,NA,NA
12927,35203875,2022,RR(S5)FRR(S5)LRWL,RR{nnr:S5}FRR{nnr:S5}LRWL,L6S1,Free,Free,Macrocyclized,L,"(R8) and (S5) indicate stapled using 8- and 5-atom linkers, respectively.",11,Antibacterial,∼5 % Hemolysis at 50 µM,Sheep,Synthetic,NA,Non-hemolytic,NA,NA
12928,35203875,2022,RRLFRR(S5)LRW(S5),RRLFRR{nnr:S5}LRW{nnr:S5},L6S2,Free,Free,Macrocyclized,L,"(S5) and (S5) indicate stapled using 5- and 5-atom linkers, respectively.",11,Antibacterial,∼55 % Hemolysis at 50 µM,Sheep,Synthetic,NA,NA,NA,NA
12929,35203875,2022,RRL(R8)RRILRW(S5),RRL{nnr:R8}RRILRW{nnr:S5},L6S3,Free,Free,Macrocyclized,L,"(R8) and (S5) indicate stapled using 8- and 5-atom linkers, respectively.",11,Antibacterial,<5 % Hemolysis at 50 µM,Sheep,Synthetic,NA,Non-hemolytic,NA,NA
12933,35203875,2022,KRI(R8)QRIKKW(S5)R,KRI{nnr:R8}QRIKKW{nnr:S5}R,L8S3,Free,Free,Macrocyclized,L,"(R8) and (S5) indicate stapled using 8- and 5-atom linkers, respectively",12,Antibacterial,∼20 % Hemolysis at 50 µM,Sheep,Synthetic,NA,Non-hemolytic,NA,NA
12960,35335979,2022,KKWVPWKKKWVPWKKIANIL,KKWVPWKKKWVPWKKIANIL{ct:Amid},T1CEh-KKPWW2,Amidation,Free,Branched,L,None,20,"Antibacterial, Anti-biofilm",63 % Hemolysis at 256 µM,Horse,Synthetic,α-Helix,NA,NA,NA
13029,35464194,2022,VKRFS5KFFS5KLKKLV,VKRF{nnr:S5}KFF{nnr:S5}KLKKLV{ct:Amid},B1-L-2,Amidation,Free,Stapled,L,"S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5",15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,NA
13030,35464194,2022,VKRFKS5FFRS5LKKLV,VKRFK{nnr:S5}FFR{nnr:S5}LKKLV{ct:Amid},B1-L-3,Amidation,Free,Stapled,L,"S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5",15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,NA
13031,35464194,2022,VKRFKKFFS5KLKS5LV,VKRFKKFF{nnr:S5}KLK{nnr:S5}LV{ct:Amid},B1-L-4,Amidation,Free,Stapled,L,"S5 = (S)-2-(4-pentenyl) alanine, stapled b/w S5 and S5",15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,NA
13032,35464194,2022,VR8RFKKFFS5KLKKLV,V{nnr:R8}RFKKFF{nnr:S5}KLKKLV{ct:Amid},B1-L-5,Amidation,Free,Stapled,L,"S5 = (S)-2-(4-pentenyl) alanine, stapled b/w R8 and S5",15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,NA
13033,35464194,2022,VKRFR8KFFRKLS5KLV,VKRF{nnr:R8}KFFRKL{nnr:S5}KLV{ct:Amid},B1-L-6,Amidation,Free,Stapled,L,"R8 = (R)-2-(7-octenyl) alanine, S5 = (S)-2-(4-pentenyl) alanine, stapled b/w R8 and S5",15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,NA
13034,35464194,2022,VKRFKR8FFRKLKS5LV,VKRFK{nnr:R8}FFRKLK{nnr:S5}LV{ct:Amid},B1-L-7,Amidation,Free,Stapled,L,"R8 = (R)-2-(7-octenyl) alanine, S5 = (S)-2-(4-pentenyl) alanine, stapled b/w R8 and S5",15,"Antibacterial, Cytotoxic",50 % Hemolysis at > 80 µM,Rabbit,Bungarus Fasciatus,NA,Low hemolytic,NA,NA
13035,35647551,2022,BFKVARRTVAKYRENIeL,{nnr:B}FKVARRTVAKYRE{nnr:NIe}L{nt:Acet}{ct:Amid},WT,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,0.12 ± 0.07 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13036,35647551,2022,BFKVXRRTXAKYRENIeL,{nnr:B}FKV{nnr:X}RRT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid},2,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,6.6 ± 0.3 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13037,35647551,2022,BFKVARRXVAKXRENIeL,{nnr:B}FKVARR{nnr:X}VAK{nnr:X}RE{nnr:NIe}L{nt:Acet}{ct:Amid},10,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,10.7 ± 0.3 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13038,35647551,2022,BFKVXRRTXAKYRENIe|,{nnr:B}FKV{nnr:X}RRT{nnr:X}AKYRE{nnr:NIe}|{nt:Acet}{ct:Amid},14,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,35.0 ± 0.5 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13039,35647551,2022,BFKVXKRTXAKYRENIeL,{nnr:B}FKV{nnr:X}KRT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid},17,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,3.3 ± 0.7 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13040,35647551,2022,BFKVXRKTXAKYRENIeL,{nnr:B}FKV{nnr:X}RKT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid},18,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,3.3 ± 0.05 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13041,35647551,2022,BFKVXRRTXGKYRENIeL,{nnr:B}FKV{nnr:X}RRT{nnr:X}GKYRE{nnr:NIe}L{nt:Acet}{ct:Amid},31,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,0.53 ± 0.05 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13042,35647551,2022,BFRVXRRTXAKYRENIeL,{nnr:B}FRV{nnr:X}RRT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid},33,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,1.5 ± 0.03 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13118,35740895,2022,FLSGIVGMLaKLFKK-FLSGIVGMLDAKLF-FLSGIVGMLDAKLF,FLSGIVGMLA{d}KLFKK-FLSGIVGMLDAKLF-FLSGIVGMLDAKLF{ct:Amid},[G10a]3 SHa,Amidation,Free,Branched,Mix,"a = D-alanine, Linked b/w Lys27 and Phe27",41,"Antimicrobial, Antiproliferative",50 % Hemolysis at 10.46 ± 0.36 µM,Human,Dendrimeric Analog Of Temporin-Sha,α-Helix,NA,NA,NA
13123,35740895,2022,FLSGIVGMLaKLFKK-FLSGIVGMLDAKLF-FLSGIVGMLDAKLF,FLSGIVGMLA{d}KLFKK-FLSGIVGMLDAKLF-FLSGIVGMLDAKLF{ct:Amid},[G10a]3 SHa,Amidation,Free,Branched,Mix,"a = D-alanine, Linked b/w Lys27 and Phe27",41,"Antimicrobial, Antiproliferative",100 % Hemolysis at 100 µM,Human,Dendrimeric Analog Of Temporin-Sha,α-Helix,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,NA